Xinnate - Lund

Xinnate is a biopharmaceutical company devoted to creating cutting-edge peptide-based medications for the prevention and treatment of inflammatory illnesses and infections. Specializing in the context of skin and wounds, surgical materials, and biomaterials, they have developed their patented BioC wound gel, a hydrogel created to treat burn wounds. This innovative technology is built upon extensive research of biological systems that are designed to maintain community health, defend against external threats, and promote natural healing.